Latest News

Thursday, October 19, 2017 | PracticalDermatology.com, Research and Publications, Melanoma

Understanding How and When UV Rays Cause Melanomas

When melanocyte stem cells accumulate a sufficient number of genetic mutations, they can become the cells where melanomas originate, Cornell University researchers report. Under normal conditions, …

Read the full story

Thursday, October 19, 2017 | PracticalDermatology.com, Research and Publications, Melanoma

Study: Risk of Indoor Tanning Dependency Highest in Women with Depressive Symptoms

More than one in five young, white women who have used indoor tanning at least once in the past year show signs of being addicted to the high dose of ultraviolet (UV) radiation from tanning beds. I…

Read the full story

Tuesday, October 17, 2017 | PracticalDermatology.com, Research and Publications, American Academy of Dermatology

Timing of Melanoma Diagnosis, Treatment Can Mean Life or Death

The sooner melanoma patients are treated, the better their survival, particularly for stage I melanoma, according to a new study from the Cleveland Clinic. The research appears online today in the …

Read the full story

Tuesday, October 17, 2017 | FDA Approval/Clearance, PracticalDermatology.com

FDA Clears Xstrahl Photoelectric Therapy System

Xstrahl has received FDA 510K clearance for the marketing of its latest skin cancer therapy device. The Photoelectric Therapy System is a compact and ergonomic superficial X-Ray therapy system operati…

Read the full story

Tuesday, October 17, 2017 |

Menlo Therapeutics Expands Management Team

Menlo Therapeutics Inc., a late stage biopharmaceutical company, is developing a neurokinin 1 (NK‐1) receptor antagonist (serlopitant) for the treatment of pruritus associated with various underlyin…

Read the full story

Tuesday, October 17, 2017 | Personnel/Company News

Prugen Pharmaceuticals Takes Action to Aid Hurricane Relief Efforts

In the wake of several devastating and destructive hurricanes in the continental US and Puerto Rico, PruGen Pharmaceuticals is helping to those in need. The PruGen Foundation, a nonprofit organization…

Read the full story

Monday, October 16, 2017 | PracticalDermatology.com, Research and Publications, National Rosacea Society

National Rosacea Society Awards New Grants; Call for 2018 Proposals

The National Rosacea Society (NRS) awarded funding for three new studies, in addition to continuing support for three ongoing studies, as part of its research grants program. Dr. Benjamin Kaffenber…

Read the full story

Monday, October 16, 2017 | PracticalDermatology.com, Research and Publications

Ortho Dermatologics: Long-term Efficacy Data for Siliq

Siliq™ (brodalumab) injection provided sustained high levels of skin clearance (PASI 100) over more than two years in patients with moderate-to-severe psoriasis, according to data presented at t…

Read the full story

Friday, October 13, 2017 | FDA Approval/Clearance, PracticalDermatology.com, Product Launches and Updates

FDA Approves Stelara for Treatment of Adolescents with Moderate To Severe Plaque Psoriasis

The FDA approved an expanded indication for Janssen Biotech, Inc.'s Stelara (ustekinumab) for the treatment of adolescents (12 years of age or older) with moderate to severe plaque psoriasis who a…

Read the full story

Friday, October 13, 2017 | Personnel/Company News, PracticalDermatology.com, Solta, Valeant NJ

James P. Hartman Named New Vice President and General Manager at Solta Medical

James P. Hartman is the new Vice President and general manager at Solta Medical, a division of Valeant Pharmaceuticals North America LLC. Mr. Hartman joined Solta Medical from Merz Aesthetics (a di…

Read the full story

Thursday, October 12, 2017 | FDA Approval/Clearance, PracticalDermatology.com, Product Launches and Updates, Galderma

FDA Approves Injection of Restylane Silk via Cannula for Lip Augmentation

The FDA has approved the use of a small blunt tip cannula with Galderma's Restylane Silk for lip augmentation. Restylane Silk was the first FDA-approved hyaluronic acid (HA) dermal filler specific…

Read the full story

Wednesday, October 11, 2017 | Personnel/Company News, PracticalDermatology.com

Biofrontera Appoints Jeffrey Holm as VP of Marketing

   Biofrontera AG, which specializes in the treatment of sun-induced skin cancer, has appointmented Jeffrey Holm as Vice President of Marketing, to further strengthen its U…

Read the full story

Wednesday, October 11, 2017 | PracticalDermatology.com, Product Launches and Updates

MDRejuvena Launches Vivatia Skin Lightening Product Line in US

MDRejuvena, Inc., has launched the Vivatia skin lightening product line in the US. Vivatia incorporates a patented, proprietary foam technology that enhances the dispersion and absorption of active in…

Read the full story

Monday, October 09, 2017 | Personnel/Company News, PracticalDermatology.com, Product Launches and Updates, Avene

Eau Thermale Avène Expands its #AveneHope Program

In recognition of Eczema Awareness Month and National Bullying Prevention Awareness Month this October, Eau Thermale Avène is expanding its #AveneHope program…

Read the full story

Monday, October 09, 2017 | American Society for Dermatologic Surgery

ASDS Elects New Officers, Board Members

The American Society for Dermatologic Surgery (ASDS) introduced their new Vice President and three members of the Board of Directors the 2017 ASDS Annual Meeting in Chicago. Their terms officially beg…

Read the full story
Load More